Utilizing abundant experience and achievements, various modifications such as phosphorothioate can be made!
Ajinomoto Bio-Pharma Services and GeneDesign have extensive experience and a proven track record in LNA oligonucleotide synthesis and oligonucleotide synthesis that includes BNA. "LNA" is a type of synthetic nucleic acid known for its stability and specificity to complementary strands, while "BNA" is a general term for synthetic nucleic acids that are known for their high stability and increased specificity to complementary strands. In addition to long-chain DNA-LNA chimeric oligos and DNA-BNA chimeric oligos, we can also perform various modifications such as phosphorothioate modification and terminal modifications. [Features] ■ LNA Synthesis - Supplied by us for research and development purposes - Supports terminal modifications, large-scale synthesis, and shipping for in vivo experimental grades ■ BNA Synthesis - Established technology for synthesizing and purifying oligonucleotides with various combinations - Provides LNA, BNA-NC (N-Me), and BNA-NC (N-H) *For more details, please refer to the external link page or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the external link page or feel free to contact us.
Price information
We have set a special discounted price for LNA Gapmers (approximately 20mer, fully phosphorothioated). We offer a consistent price regardless of the number of bases, so please feel free to contact us.
Price range
P2
Delivery Time
P4
※*The quantity may vary depending on production. Please feel free to contact us.*
Applications/Examples of results
For more details, please refer to the external link page or feel free to contact us.
Company information
Ajinomoto Bio-Pharma Services and GeneDesign, Inc. are engaged in the production of oligonucleotides, incorporating the latest technologies and patent licenses from various research institutions. We supply distinctive nucleic acid materials, including the introduction of artificially modified nucleic acids and the addition of functional molecules, contributing to the development of new technologies in the gene-related fields (such as drug development, diagnostic technology development, and bio-research technology development). Currently, the demand for various synthetic nucleic acids is expanding from cell culture levels to animal testing and further to clinical trials. Our company has established a system capable of supplying everything from research reagents to investigational drugs at all scales, and we are advancing research and development daily as a company that can significantly contribute to the creation of nucleic acid pharmaceuticals and the practical application of diagnostic systems. For the future of medicine, we aim to be a company that contributes to the welfare and health of people through the development of nucleic acid manufacturing technologies, actively working on the development of next-generation nucleic acid drugs and diagnostic materials.
![Oligo DNA derived from microbial genomes [Shinshu University Agriculture]](https://image.mono.ipros.com/public/product/image/a52/2000829503/IPROS3898321288668949087.png?w=280&h=280)
